BIOBRAILLE Trademark

Trademark Overview

On Tuesday, April 20, 2021, a trademark application was filed for BIOBRAILLE with the United States Patent and Trademark Office. The USPTO has given the BIOBRAILLE trademark a serial number of 90657779. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Friday, September 13, 2024. This trademark is owned by Bone Pharm, LLC. The BIOBRAILLE trademark is filed in the Medical Instrument Products category with the following description:

Implants consisting of artificial materials
biobraille

General Information

Serial Number90657779
Word MarkBIOBRAILLE
Filing DateTuesday, April 20, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateFriday, September 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 18, 2022

Trademark Statements

Pseudo MarkBIO BRAILLE
Goods and ServicesImplants consisting of artificial materials

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, July 27, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBone Pharm, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressTampa, FL 33604
Party NameBone Pharm, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressTampa, FL 33604

Trademark Events

Event DateEvent Description
Friday, April 23, 2021NEW APPLICATION ENTERED
Tuesday, July 27, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 13, 2021ASSIGNED TO EXAMINER
Tuesday, December 14, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 18, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, December 29, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 18, 2022PUBLISHED FOR OPPOSITION
Tuesday, March 15, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 15, 2022SOU TEAS EXTENSION RECEIVED
Thursday, September 15, 2022SOU EXTENSION 1 FILED
Thursday, September 15, 2022SOU EXTENSION 1 GRANTED
Friday, March 3, 2023SOU EXTENSION 2 GRANTED
Thursday, September 7, 2023SOU EXTENSION 3 FILED
Saturday, September 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 3, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 3, 2023SOU EXTENSION 2 FILED
Tuesday, March 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 7, 2023SOU TEAS EXTENSION RECEIVED
Thursday, September 7, 2023SOU EXTENSION 3 GRANTED
Saturday, September 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 12, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 12, 2024SOU EXTENSION 4 GRANTED
Wednesday, March 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 13, 2024SOU TEAS EXTENSION RECEIVED
Friday, September 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 13, 2024SOU EXTENSION 5 FILED
Friday, September 13, 2024SOU EXTENSION 5 GRANTED
Tuesday, March 12, 2024SOU EXTENSION 4 FILED

Related Keywords

biobraille materials artificial consisting implants